4
Changes in Ownership
Natera, Inc. Filed Acc 0001415889-25-011192
PRESIDENT, CLINICALDIAGNOSTICS sold 296 shares at an average $145.56 ($43,085)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-21 | Sale : show line 1 in the form 10b5-1 | −292 | $145.54 | $42,498 | 141,490 | D |
| 2025-04-21 | Sale : show line 2 in the form 10b5-1 | −4 | $146.85 | $587 | 141,486 | D |
| Open-market sales · 296 sh · avg $145.56 · $43,085 | ||||||
Loading xslF345X05/form4-04222025_090404.xml…